Skip to Content
No Fees Unless We Win 855-948-5098
Exhibits Client Focused. Trial Ready. Billions Won.

Taiwanese Hemophiliacs Infected by US Made HIV-Contaminated Medications: Exhibits

  • Szmuness 1975 “On the Role of Sexual Behavior in the Spread of Hepatitis B Infection”
  • Exhibit 1: Cutter Memo to Taiwan supplier re sales of AHF since 1977, 2 April 1985
  • Exhibit 2: Cutter Memo re meeting with Taiwan Dept of Health, 4-5 Feb 1997
  • Exhibit 3: Cutter Memo re heat treatment killing AIDS virus, 17 May 1984
  • Exhibit 4: Cutter Note re AHF study and chimpanzees developing AIDS-like symptoms, 14 Dec 1982
  • Exhibit 5: July 1982 MMWR reporting hemophiliacs showing symptoms of
    disease observed in gay men
  • Exhibit 6: Oct 1984 MMWR reporting increasing cases of AIDS in hemophiliacs
  • Exhibit 7: Cutter Memo re plasma screening test recommended by the FDA, 19 Dec 1983
  • Exhibit 8: Cutter Memo re FDA asking Cutter to voluntarily exclude gays from plasma collection, 30 Aug 1982
  • Exhibit 9: Cutter Memo re FDA asking Cutter to exclude high risk donors, including prisoners, 21 Dec 1982
  • Exhibit 10: Advertisements in various gay magazines for plasma donors exposed to hepatitis
  • Exhibit 11: Cutter letter to Warden of Arizona State Prison in Florence re FDA concern re prisoner plasma, 19 Jan 1983
  • Exhibit 12: Letter from Cutter’s Oakland Plasma Center to Cutter, that center was found to be in non-compliance re plasma collection from IV drug users, 19 May 1981
  • Exhibit 13: Cutter Memo re FDA asking for exclusion of plasma from high risk donors, 13 Dec 1982
  • Exhibit 14: Transcript of Steven Ojala (Cutter) presentation to FDA Committee opposing mandatory recalls, 19 July 1983
  • Exhibit 15: Internal Cutter Memo from Mozen that heat treated AHF would probably be safer, 4 Jan 1983
  • Exhibit 16: Letter from FDA to Hyland / Travenol approving their heat treatment license, 21 March 1983
  • Exhibit 17: Letter from FDA to Miles (Cutter) approving their heat treatment license, 29 Feb 1984
  • Exhibit 18: Letter from Cutter to FDA, date 9 Aug 1985, that they ceased making and distributing non-heat treated product on 21 June 1985
  • Exhibit 19: Letter from FDA to Miles/Cutter acknowledging Cutter’s letter of 9 Aug 1985
  • Exhibit 20: Confidential Cutter Memo of 15 Nov 1984 regarding excess inventory of non-heated AHF
  • Exhibit 21: Cutter Telex of 29 Nov 1984 regarding continued sale of non-heated AHF to the Far East
  • Exhibit 22: Cutter’s 1984 Far East Marketing Memo stating that a recall would cost
    Cutter $2 Million during 1984
  • Exhibit 23: Cutter’s 1985 Far East Marketing Memo stating Cutter has no immediate plans to stop selling non-heated AHF, because AIDS was not yet an issue in the Far East, and that “hysteria over AIDS” could cost them to lose sales and profit
  • Exhibit 24: Telex from Cutter to Hong Kong supplier, dated 6 May 1985, stating that non-heated product is still being sold in Taiwan and other countries, describing non-heated AHF as “the same fine product”
  • Exhibit 25: Cutter Memo dated 30 May 1985, regarding FDA request to Cutter to stop making
    non-heated AHF
  • Exhibit 26: Cutter telex dated 31 Oct 1983, recalling AHF lots containing plasma from Austin donor who died of AIDS
  • Exhibit 27: Cutter Memo of 4 Nov 1983 regarding recall due to Austin donor “diagnosed
    as having AIDS”
  • Exhibit 28: Cutter Telex to Taiwan supplier regarding recall, saying donor was “suspected of AIDS”
  • Exhibit 29: Cutter Letter introducing sales manual for heat treated AHF, dated 12 April 1984
  • Exhibit 31: Cutter Marketing Bulletin dated 26 June 1985 saying “Effective immediately, no further exports of non-heat treated AHF” would be made
  • Exhibit 32: Cutter telex to Taiwan supplier, dated 20 Sept 1985, offering exchange of heat-treated AHF for the non-heat treated AHF
  • Exhibit 33: Cutter Memo regarding international AIDS symposium in April 1985, and the amount of information now known about AIDS, in which it was recommended that non-heated AHF
    no longer be used
  • Exhibit 34: Jury verdict of $2 Million in JKB case in Indiana, 20 March 1997
  • Exhibit 35: Jury verdict of $35.3 Million in Dixon case in Louisiana, 15 March 1999
  • Exhibit 36: News release dated 19 Feb 1998, regarding Bayer providing “humanitarian aid” to Taiwanese hemophiliacs who contracted HIV
  • Exhibit 37: News release dated 14 Feb 1998, wherein Bayer claims it had won all litigation cases throughout the world
  • Exhibit 39: Bayer responses to Discovery requests, 13 Feb 2008, listing participants in the Taiwan aid negotiations
  • Exhibit 40: Bayer responses to Discovery requests, 26 Oct 2007, regarding Taiwan aid negotiations
  • Exhibit 42: US Court of Appeals decision on Gruca, which notes that their decision was based upon the fact that the AHF used which infected the person who died of AIDS, was made by another manufacturer other than Cutter
  • Exhibit 42a: Gruca case settlement with Alpha Therapeutic Corporation, 21 Jan 2003
  • Exhibit 44: Paragraph 9 of Taiwan Humanitarian Aid agreement, regarding additional compensation to Taiwan claimants, if Bayer pays higher compensation to others
  • Exhibit 45: Paragraph 18 of attorney’s declaration, that Taiwan humanitarian agreements were signed between 1998 and 2002
  • Exhibit 46: Letter of 11 May 2004 to Bayer, requesting enforcement of the scale-up clause of the Taiwan agreement, and increased compensation to Taiwan victims
  • Exhibit 47: New York Times story of 22 May 2003, regarding Bayer’s dumping of infective product in overseas countries
  • Exhibit 54: Bayer letter of 16 Feb 1998 to Taiwan Department of Health regarding negotiations on humanitarian aid
  • Exhibit 63: Cutter memo dated 27 Jan 1982, that “hepatitis free” AHF product was being tested, and that Dr. Louis Aledort stated “that once this product is licensed, it would be unethical to place a patient on other therapy”
  • Exhibit 64: Cutter Memo dated 1 June 1983 regarding hemophiliacs diagnosed with AIDS had used AHF, and that heat-treated AHF in Europe appeared free of hepatitis and thus was safer
  • Exhibit 65: Cutter Memo dated 6 June 1983 regarding heat treated AHF appearing safer
  • Exhibit 66: Cutter Marketing Bulletin of 6 July 1983 downplaying heat treatment,
    saying not proven, etc
  • Exhibit 67: Cutter’s ECHO publication to hemophiliacs, dated May 1983, stating there is “no evidence”, and downplaying heat treatment of AHF
  • Exhibit 68: Cutter Memo of 22 Nov 1983 stating Cutter had made a “corporate commitment” to produce heat treated AHF, that they had a “quality heat treated process” that would be available in early 1984

A sample of hemophiliac lawsuits against AHF manufacturers:

Federal Regulations requiring companies to use plasma from “normal, healthy donors”:

OVER $4 billion

in verdicts & Settlements

Our top priority is to devise customized legal strategies that are tailored to the unique legal needs of our clients, no matter how simple or complicated their situations, might be.

  • $10 Million Settlement A Major Foreign Plane Crash

    Wisner Baum obtained a $10 million settlement for the death of a passenger in a major foreign plane crash.

  • $14 Million Settlement A Major US Plane Crash

    Wisner Baum obtained a $14 million settlement for the death of a passenger in a major US plane crash.

  • $17.5 Million Settlement A Major US Plane Crash

    Wisner Baum obtained a $17.5 million settlement on behalf of a client who was killed in a major U.S. plane crash.

  • $10 Million Settlement Celexa-Lexapro Pediatric Class Action

    $10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.

  • $8.5 Million Verdict Commercial Truck Accident

    Wisner Baum secured a $8.5 million wrongful death verdict against the food industry company, Tyson Foods, for the wrongful death of a young man.

Client-Focused Representation


We believe our track record speaks for itself. But you don’t have to take our word for it. See what our clients have to say about working with us.

    "I Can’t Imagine a Better Law Firm"

    Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.

    - Best Law Firms Survey
    "They Are About Changing the Systems..."

    Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.

    - Kim Witczak
    "Top Legal Minds in the Country"

    The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.

    - From Best Lawyers® Best Law Firms
    "Diligent & Professional Representation"

    Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.

    - W.T.
    "Our Best Interest Was Always Number One on Your List"

    A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.

    - G.C. & C.C
    "We Have Never Met a More Wonderful Group of People"

    It is obvious that the people at Wisner Baum believe in what they do. And that you all really care about your clients.

    - The B. Family
    "They Worked Very Hard and Kept in Contact, Which Is Very Important to Me"

    I appreciate that you care about how I feel and that you take time to use your talents to ensure your every contact with me is warmly professional.

    - A.D.B.
    "Your Expertise in This Field Gave Me the Utmost Trust and Confidence"

    I wanted a fair settlement within an appropriate time frame, and without any public scrutiny. With your hard work and dedication, we were able to achieve those goals.

    - T.O.
Nationwide Legal Advocacy Call (855) 948-5098 to Learn About Your Legal Options Free & Confidential Consultation